Harga kembali 1 minggu1.58%
Harga kembali 1 Bulan-5.60%
Harga kembali 3 Bulan-6.86%
Harga kembali 6 Bulan3.09%
Harga Tertinggi (52 Minggu)157.3
Harga Terendah (52 Minggu)107.76
Latar Belakang Perusahaan
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Summary
Valuation Information
Current PE Ratio (TTM)17.18
Forward PE Ratio15.22
Current Price to Book Value6.67
Current Price to Sales5.28
EV to Revenue5.83
EV to EBITDA11.97
PEG Ratio0.31
Per Share
Current EPS (Annualized)7.35
Diluted EPS (TTM)7.35
Revenue Per Share23.92
Current Book Value Per Share18.93
Dividend
Dividend Per Share3.19
Dividend Yield0.0253
Ex Dividend Date2026-06-15
Dividend Payment Date2026-06-29
Income Statement
EBITDA14738000000
Profit Margin0.31
Operating Margin0.393
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
